Insulin tolerance test predicts non response vs. sustained efficacy of Liraglutide on glycemic control in type 2 diabetes patients: A prospective real-world setting study-Reference-Cited by-同舟云学术

Insulin tolerance test predicts non response vs. sustained efficacy of Liraglutide on glycemic control in type 2 diabetes patients: A prospective real-world setting study

Published:2018-03 Issue: Volume:137 Page:20-27
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Germain Natacha,Khalfallah Yadh,Estour Bruno,Galusca Bogdan

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference38 articles.

1. The pharmacologic treatment of type 2 diabetes Injectable medications;Tran;Ann Pharmacother,2015

2. Biology of incretins: GLP-1 and GIP;Baggio;Gastroenterology,2007

3. Glucagon-like peptide-1 7–36: a physiological incretin in man;Kreymann;Lancet,1987

4. Glucagon-like peptide-1: a potent regulator of food intake in humans;Gutzwiller;Gut,1999

5. GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans;Naslund;Am J Phys.,1999

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective Effects of Astragaloside IV on Uric Acid-Induced Pancreatic β-Cell Injury through PI3K/AKT Pathway Activation;Evidence-Based Complementary and Alternative Medicine;2022-01-10

2. Pathogenetic Changes in the Expression of Apoptotic Marker Caspase-3 in Patients with Type IІ Diabetes Mellitus and Excess Body Weight and Obesity;Ukraïnsʹkij žurnal medicini, bìologìï ta sportu;2020-11-01

3. Durability of glycaemic control in type 2 diabetes: A systematic review and meta‐analysis for its association with body weight changes;Diabetes, Obesity and Metabolism;2020-10-25

4. Predictive factors associated with three years of response to HbA1c goals with exenatide QW or insulin glargine: Post‐hoc analysis of the DURATION‐3 study;Diabetes, Obesity and Metabolism;2019-04

5. Predictive factors of efficacy of combination therapy with basal insulin and liraglutide in type 2 diabetes when switched from longstanding basal-bolus insulin: Association between the responses of β- and α-cells to GLP-1 stimulation and the glycaemic control at 6 months after switching therapy;Diabetes Research and Clinical Practice;2018-10